New Terminology for PCOS Aimed at Reflecting Whole-Body Impact

Health professionals in Jersey are advocating for a shift in terminology regarding a metabolic disorder that impacts over 170 million women worldwide. The International PCOS Network officially implemented the change on May 12, renaming Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The organization stated that this update is designed to enhance public understanding and facilitate more accurate diagnosis and treatment.

Experts argue that the previous acronym, PCOS, misleadingly suggested the disorder was confined to the ovaries. In reality, it is a systemic issue affecting the entire body. Jessica Pinel, chair of PCOS Jersey and a nutritionist, emphasized this distinction. "The term PCOS limited the condition to having an effect on women's ovaries, whereas we know that it is a full-body condition," Pinel explained.

According to the NHS, individuals with PCOS or PMOS typically experience elevated male hormone levels, which can lead to weight gain, irregular menstrual cycles, and other complications. Pinel, who received her diagnosis three years ago after spending over £3,000 on treatment, noted the wide variety of symptoms patients face. "We know that it can be fatigue, hair growth in unwanted places, acne, brain fog even, irregular periods and infertility," she said. She added that the new name hopes to encourage women to seek comprehensive support for this diverse range of symptoms, which affect daily life in unique ways.

Pinel also highlighted the dangers of relying on social media for health information, citing a 2024 BBC investigation that revealed influencers selling counterfeit cures for PCOS. She warned against the misinformation prevalent on platforms like TikTok, Instagram, and Facebook. Instead, she urged individuals to pursue professional guidance. "We can't just put the onus on the women themselves to seek out that sort of education," she said, advising that those seeking knowledge must be "really, really careful."

She also encouraged patients to advocate for themselves. "In terms of diagnosis, you are always entitled to a second opinion," Pinel advised. She shared her own experience, noting that she underwent exploratory tests and sought a secondary opinion after initial diagnoses failed to resonate with her understanding of her body. "If you feel like you're not being seen or heard, then please go and seek that second opinion because you deserve it."

Jersey GP Dr. Jessica Langtree-Marsh described PCOS/PMOS as "hugely under-researched and hugely misunderstood." She criticized the medical community’s historical tendency to view the condition merely as a barrier to pregnancy, stating, "We see it as just simply: 'Come back when you want to have a baby and we'll fix it then.' Actually, we need to look at this as a lifespan condition."

Dr. Langtree-Marsh noted that the original condition was discovered 70 years ago by surgeons Dr. Irving Stein and Dr. Michael Leventhal, who initially called it Stein-Leventhal Syndrome. They identified the disorder in women with amenorrhea by observing specific ovarian characteristics. She explained that while the name PCOS acknowledged ovarian involvement, it failed to capture the systemic nature of the disease. The rebranded PMOS aims to correct this by recognizing the condition's broader impact.

"Although the name doesn't exactly roll off the tongue," Langtree-Marsh admitted, she expressed satisfaction that the new definition moves away from a narrow focus. She hopes the change will promote broader treatment approaches, shifting the focus from solely using contraceptive pills to incorporating metabolic medications to better combat the condition.

The Jersey government has confirmed that a women’s health strategy, required by the Government Plan, is scheduled for publication later this year. Dr. Langtree-Marsh stressed that early diagnosis and education are essential to ensuring individuals receive the correct care.

Source: BBC News Generated at: 2026-05-26 05:27:03 UTC